# FDA Inspection 1123693 - Rafarm S.A. - March 11, 2020

Source: https://www.keypedia.com/records/fda_inspections/rafarm-sa/0d18ea8e-dd55-4388-9680-c88b53caa1b0
Source feed: FDA_Inspections

> FDA Inspection 1123693 for Rafarm S.A. on March 11, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1123693
- Company Name: Rafarm S.A.
- Inspection Date: 2020-03-11
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1300434 - 2024-06-21](https://www.keypedia.com/records/fda_inspections/rafarm-sa/a24b8d41-94b2-407f-a4d0-5ed1db63763e)
- [FDA Inspection 1225663 - 2023-05-19](https://www.keypedia.com/records/fda_inspections/rafarm-sa/b8f780cb-150f-479c-972b-49798ad3c1d3)
- [FDA Inspection 1155967 - 2021-06-04](https://www.keypedia.com/records/fda_inspections/rafarm-sa/78b90921-d386-4f46-9545-bd2ea23f48d8)
- [FDA Inspection 1111463 - 2018-05-31](https://www.keypedia.com/records/fda_inspections/rafarm-sa/6429f57b-1cfa-49d1-9f63-9c745663982a)

Company: https://www.keypedia.com/companies/rafarm-sa/147e9812-6247-4b31-82b4-c444b23955ce

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c